Building Resilient Biotechnology Research in the Shadow of The Biosecure Act

When

March 28, 2024 — Thursday
7:00 pm — 9:30 pm

Where
HYBRID EVENT: CityPoint Meeting Room, 1st Floor AND VIRTUAL

The Biosecure Act, if passed, would severely restrict collaborations between US companies and Chinese Contract Research Organizations (CROs). To help manage interruptions in biotech research, we invite you to attend the seminar either in-person or online. 

REGISTRATION IS NOW CLOSED for this event.

Contact Jaclyn Braga at jbraga@morse.law with questions.


Moderated by:
Martin Zhang, Partner, Morse

Panelists:
Matthew Bock, Managing Partner, Bock Trade Law
Jonathan D. Gworek, Partner, Morse
Faith D. Kasparian, CIPP/US, Partner, Morse
Erica Wang, General Counsel, TandemAI

Presented by:
Morse
North America 100 Angel Investment LLC

Contact
Jaclyn Braga
Director of Marketing & Business Development
Vcard